PI Publications

Khanvilkar S, Mittra I

Raghuram GV, Tripathy BK, Avadhani K, Shabrish S, Khare NK, Lopes R, Pal K, Mittra I

Raghuram GV, Pal K, Sriram G, Khan A, Joshi R, Jadhav V, Shinde S, Shaikh A, Rane B, Kangne H, Mittra I

Mittra I

Shabrish S, Pal K, Khare N, Satsangi D, Pilankar A, Jadhav V, Shinde S, Raphael N, Sriram G, Lopes R, Raghuram G, Tandel H, Mittra I

Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav V, Shinde S, Jadhav S, Gota V, Mittra I

Agarwal A, Khandelwal A, Pal K, Khare NK, Jadhav V, Gurjar M, Punatar S, Gokarn A, Bonda A, Nayak L, Kannan S, Gota V, Khattry N, Mittra I

Pilankar A, Singhavi H, Raghuram G, Siddiqui S, Khare N, Jadhav V, Tandel H, Pal K, Bhattacharjee A, Chaturvedi P, Mittra I

Pal K, Raghuram GV, Dsouza J, Shinde S, Jadhav V, Shaikh A, Rane B, Tandel H, Kondhalkar D, Chaudhary S, Mittra I

Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA

Shabrish S, Mittra I

Singhavi H, Khare N, Singh A, Khandelwal A, Kannan S, Patil A, Mittra I, Chaturvedi P

Tripathy B, Pal K, Shabrish S, Mittra I

Mishra GA, Pimple SA, Mittra I, Badwe RA

Mehrotra S, Mittra I

Mittra I, Pal K, Pancholi N, Tidke P, Siddiqui S, Rane B, D'souza J, Shaikh A, Parab S, Shinde S, Jadhav V, Shende S, Raghuram GV

Raghuram GV, Chaudhary S, Johari S, Mittra I

Chaudhari S, Mittra I

Is inflammation a direct response to dsDNA breaks? Mutat Res Fund Mol Mech Mutagen808: 48-52.

Kirolikar S, Prasannan P, Raghuram GV, Pancholi N, Saha T, Tidke P, Chaudhari P, Shaikh A, Rane B, Pandey R, Wani H, Khare NK, Siddiqui S, D'souza J, Prasad R, Shinde S, Parab S, Nair NK, Pal K, Mittra I

Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin. Annals of Oncology. 28: 2119-2127. doi: 10.1093/annonc/mdx318.

Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Disc. 3: 17015; doi: 10.1038/cddiscovery.2017.15.

Physical shearing imparts biological activity to DNA and ability to transmit itself horizontally across species and kingdom boundaries. BMC Mol Biol. 18: 21. doi: 10.1186/s12867-017-0098-8.

Evidence for cell-free nucleic acids as continuously arising endogenous DNA mutagens. Mutat Res.793-794: 15-21. (doi: 10.1016/j.mrfmmm.2016.10.002).

Circulating nucleic acids: a new class of physiological mobile genetic elements. F1000Research. 4: 924 (doi: 10.12688/f1000research.7095.1).

A paradoxical synergism between Resveratrol and copper (II) with respect to degradation of DNA and RNA. F1000Research. 4: 1145 (doi: 10.12688/f1000research.7202.1).

Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci.40(1): 91-111.

Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst. 106(3):dju009. doi: 10.1093/jnci/dju009.

Pullulan-histone antibody nanoconjugates for the removal of chromatin fragments from systemic circulation. Biomaterials. 34(27): 6328-38. doi:10.1016/j.biomaterials.2013.05.019.

Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. 2013. Long-term effect

Nucleic acids in circulation: Are they harmful to the host? J. Biosci. 37(2): 301-312.

Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. J Clin Oncol.29(21): 2845-51. doi:10.1200 / JCO.2010.33.0738.

A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 126(4): 976-84. doi: 10.1002/ijc.24840.

Why is modern medicine stuck in a rut? Perspect Biol Med. 52(4): 500-17. doi: 10.1353/pbm.0.0131.

Clinical cancer trials in developing countries. Lancet. 349(9047): 290.

Multicentricity and recurrence of breast cancer. Lancet. 349(9046): 208

Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. Br J Cancer. 75(4): 554-8.

A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing. Br J Cancer. 74(8): 1181-7.

Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 74(5): 820-4.

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12000 randomised children. Lancet. 347(9018): 1783-8.

Breast screening: the case for physical examination without mammography. Lancet. 343(8893): 342-4.

A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? Eur J Cancer. 27(12): 1574-83.

Early detection of breast cancer in developing countries. Lancet.1(8640): 719-20.

Somatomedins and proteolytic bioactivation of prolactin and growth hormone. Cell. 38(2): 347-8.

1980. A novel "cleaved prolactin" in the rat pituitary: Part II. In vivo mammary mitogenic activity of its N-terminal 16K moiety.Biochem Biophys Res Commun. 95(4): 1760-7.

A novel "cleaved prolactin" in the rat pituitary: part I. Biosynthesis, characterization and regulatory control. Biochem Biophys Res Commun. 95(4): 1750-9.

Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J. 1(6004): 257-9.

Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet. 1(7863): 889-91.

Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet. 1(7863): 885-9.

Mammotropic effect of prolactin enhanced by thyroidectomy. Nature. 248(448): 525-6.